Anand Balakrishnan

1.6k total citations
36 papers, 1.2k citations indexed

About

Anand Balakrishnan is a scholar working on Molecular Biology, Biochemistry and Clinical Biochemistry. According to data from OpenAlex, Anand Balakrishnan has authored 36 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Biochemistry and 10 papers in Clinical Biochemistry. Recurrent topics in Anand Balakrishnan's work include Metabolism and Genetic Disorders (10 papers), Biochemical Acid Research Studies (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Anand Balakrishnan is often cited by papers focused on Metabolism and Genetic Disorders (10 papers), Biochemical Acid Research Studies (10 papers) and Drug Transport and Resistance Mechanisms (9 papers). Anand Balakrishnan collaborates with scholars based in United States, India and Germany. Anand Balakrishnan's co-authors include James E. Polli, Frank Jordan, Natalia S. Nemeria, Gordon L. Amidon, Bhagwant Rege, Jarkko Rautio, Lindsey O. Webster, Joan E. Humphreys, John P. Keogh and Joseph W. Polli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Anand Balakrishnan

34 papers receiving 1.2k citations

Peers

Countries citing papers authored by Anand Balakrishnan

Since Specialization

Citations

This map shows the geographic impact of Anand Balakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anand Balakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anand Balakrishnan more than expected).

Fields of papers citing papers by Anand Balakrishnan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anand Balakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anand Balakrishnan. The network helps show where Anand Balakrishnan may publish in the future.

Co-authorship network of co-authors of Anand Balakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Anand Balakrishnan. A scholar is included among the top collaborators of Anand Balakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anand Balakrishnan. Anand Balakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience 2025 ·PubMed ·Sreejesh Sreedharanunni, (unknown), Anand Balakrishnan, (unknown), (unknown), (unknown), Manu Jamwal, (unknown), Praveen Sharma, (unknown), (unknown), (unknown), Arihant Jain, (unknown), Alka Khadwal, (unknown), Reena Das	2
2	Identification and characterization of a novel nematode pan allergen (NPA) from Wuchereria bancrofti and their potential role in human filarial tropical pulmonary eosinophilia (TPE) 2024 ·PLoS neglected tropical diseases ·(unknown), Anand Balakrishnan, Gnanasekar Munirathinam, (unknown), Scott A. Smith, Ramaswamy Kalyanasundaram	2
3	Dose selection for biological enzyme replacement therapy indicated for inborn errors of metabolism 2023 ·Clinical and Translational Science ·Yuen Yi Hon, Jie Wang, Henrietta Abodakpi, Anand Balakrishnan, Michael Pacanowski, Sushanta Chakder, Patroula Smpokou, Kathleen Donohue, Yow‐Ming Wang	6
4	Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins 2023 ·The AAPS Journal ·(unknown), (unknown), Yuen Yi Hon, Anand Balakrishnan, Lin Zhou, (unknown), (unknown), Kimberly Maxfield, (unknown), Shiew‐Mei Huang, Yow‐Ming Wang	6
5	The Frequency, Clinico-Hematological Features, and Outcome of Acute Promyelocytic Leukemia with Variant RARA Rearrangements: A Single Center Experience from India 2023 ·Indian Journal of Hematology and Blood Transfusion ·Anjali Gupta, Sreejesh Sreedharanunni, Charanpreet Singh, Praveen Sharma, (unknown), (unknown), Anand Balakrishnan, (unknown), Shano Naseem, Man Updesh Singh Sachdeva, Alka Khadwal, Arihant Jain, Reena Das, Pankaj Malhotra	0
6	Role of regional absorption and gastrointestinal motility on variability in oral absorption of a model drug 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Ajit S. Narang, Anand Balakrishnan, J. S. Morrison, Jinjiang Li, Jennifer Wang, Huidong Gu, Katrina A. Taylor, Kenneth S. Santone, (unknown), Sophie Beyer, Xujin Lu, (unknown), Jennifer Pizzano, (unknown), (unknown), (unknown), (unknown), Margaret Batchelder, Kimberley A. Lentz	5
7	Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer’s Mouse Phenotypes 2017 ·Cell Reports ·Laura T. Haas, Santiago V. Salazar, Levi M. Smith, (unknown), Timothy Cox, Charlotte Herber, Andrew P. Degnan, Anand Balakrishnan, John E. Macor, Charles F. Albright, Stephen M. Strittmatter	86
8	Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box 2016 ·Bioorganic & Medicinal Chemistry Letters ·Hong Huang, Andrew P. Degnan, Anand Balakrishnan, Amy Easton, Michael Gulianello, Yanling Huang, (unknown), Gail K. Mattson, (unknown), Kenneth S. Santone, Arun Senapati, (unknown), Digavalli V. Sivarao, Lawrence B. Snyder, Ryan S. Westphal, Valerie Whiterock, Fukang Yang, Joanne J. Bronson, John E. Macor	21
9	Utility of PBPK Absorption Modeling to Guide Modified Release Formulation Development of Gaboxadol, a Highly Soluble Compound With Region-Dependent Absorption 2015 ·Journal of Pharmaceutical Sciences ·Filippos Kesisoglou, Anand Balakrishnan, (unknown)	26
10	Preclinical Pharmacokinetics and In Vitro Metabolism of Asunaprevir (BMS-650032), a Potent Hepatitis C Virus NS3 Protease Inhibitor 2015 ·Journal of Pharmaceutical Sciences ·Kathleen Mosure, Jay O. Knipe, (unknown), Vinod Arora, Yue‐Zhong Shu, (unknown), Fiona McPhee, Paul M. Scola, Anand Balakrishnan, Matthew G. Soars, Kenneth S. Santone, Michael Sinz	27
11	Lipoamide Channel-Binding Sulfonamides Selectively Inhibit Mycobacterial Lipoamide Dehydrogenase 2013 ·Biochemistry ·Ruslana Bryk, (unknown), (unknown), Anand Balakrishnan, Ying‐Ta Wu, Chi‐Huey Wong, Thierry Masquelin, Philip A. Hipskind, Christopher D. Lima, Carl Nathan	17
12	Influence of Allosteric Regulators on Individual Steps in the Reaction Catalyzed by Mycobacterium tuberculosis 2-Hydroxy-3-oxoadipate Synthase 2013 ·Journal of Biological Chemistry ·Anand Balakrishnan, Frank Jordan, Carl Nathan	18
13	Reaction mechanisms of thiamin diphosphate enzymes: defining states of ionization and tautomerization of the cofactor at individual steps 2009 ·FEBS Journal ·Natalia S. Nemeria, Sumit Chakraborty, Anand Balakrishnan, Frank Jordan	69
14	Interaction of Native Bile Acids with Human Apical Sodium-Dependent Bile Acid Transporter (hASBT): Influence of Steroidal Hydroxylation Pattern and C-24 Conjugation 2006 ·Pharmaceutical Research ·Anand Balakrishnan, Stephen A. Wring, James E. Polli	50
15	Ion pair-mediated transport of metoprolol across a three lipid-component PAMPA system 2006 ·Journal of Controlled Release ·Zeynep Şafak Teksin, (unknown), Anand Balakrishnan, James E. Polli	24
16	IN VITRO P-GLYCOPROTEIN INHIBITION ASSAYS FOR ASSESSMENT OF CLINICAL DRUG INTERACTION POTENTIAL OF NEW DRUG CANDIDATES: A RECOMMENDATION FOR PROBE SUBSTRATES 2006 ·Drug Metabolism and Disposition ·Jarkko Rautio, Joan E. Humphreys, Lindsey O. Webster, Anand Balakrishnan, John P. Keogh, Jeevan Kunta, Cosette J. Serabjit‐Singh, Joseph W. Polli	222
17	Bias in Estimation of Transporter Kinetic Parameters from Overexpression Systems: Interplay of Transporter Expression Level and Substrate Affinity 2006 ·Journal of Pharmacology and Experimental Therapeutics ·Anand Balakrishnan, (unknown), (unknown), Marival Bermejo, Peter W. Swaan, James E. Polli	34
18	Influence of Charge and Steric Bulk in the C-24 Region on the Interaction of Bile Acids with Human Apical Sodium-Dependent Bile Acid Transporter 2006 ·Molecular Pharmaceutics ·Anand Balakrishnan, Stephen A. Wring, Andrew Coop, James E. Polli	24
19	Development of Stably Transfected Monolayer Overexpressing the Human Apical Sodium-Dependent Bile Acid Transporter (hASBT) 2005 ·Pharmaceutical Research ·Anand Balakrishnan, Daniel J. Sussman, James E. Polli	39
20	Surfactant-mediated dissolution: Contributions of solubility enhancement and relatively low micelle diffusivity 2004 ·Journal of Pharmaceutical Sciences ·Anand Balakrishnan, Bhagwant Rege, Gordon L. Amidon, James E. Polli	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact